Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

• Jill Corre,
• Lydia Montes,
• Elodie Martin,
• Aurore Perrot,
• Denis Caillot,
• Xavier Leleu,
• Karim Belhadj,
• Thierry Facon,
• Cyrille Hulin,
• Mohamad Mohty,
• Jean Fontan,
• Margaret Macro,
• Sabine Brechignac,
• Arnaud Jaccard,
• Anne-Marie Stoppa,
• Frederique Orsini-Piocelle,
• Didier Adiko,
• Laurent Voillat,
• Faiza Keddar,
• Marly Barry,
• Helene Demarquette,
• Marie-Noelle Certain,
• Isabelle Plantier,
• Murielle Roussel,
• Benjamin Hébraud,
• Thomas Filleron,
• Michel Attal,
• Hervé Avet-Loiseau

Affiliations

Jill Corre

Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse

Lydia Montes

Hematology Department, University Hospital, Amiens

Elodie Martin

Biostatistics Department, Institut Claudius Regaud, IUCT-O, Toulouse

Aurore Perrot

Hematology Department, University Hospital, Nancy

Denis Caillot

Hematology Department, University Hospital, Dijon

Xavier Leleu

Hematology Department, University Hospital, Poitiers

Karim Belhadj

Hematology Department, University Hospital, Créteil

Thierry Facon

Hematology Department, University Hospital, Lille

Cyrille Hulin

Hematology Department, University Hospital, Bordeaux

Mohamad Mohty

Hematology Department, University Hospital, Paris

Jean Fontan

Hematology Department, University Hospital, Besancon

Margaret Macro

Hematology Department, University Hospital, Caen

Sabine Brechignac

Hematology Department, University Hospital, Bobigny

Arnaud Jaccard

Hematology Department, University Hospital, Limoges

Anne-Marie Stoppa

Hematology Department, Institut Paoli Calmettes, Marseille

Frederique Orsini-Piocelle

Hematology Department, Department Hospital, Annecy

Didier Adiko

Hematology Department, Department Hospital, Libourne

Laurent Voillat

Hematology Department, Department Hospital, Chalon-sur-Saône

Faiza Keddar

Hematology Department, Department Hospital, Valenciennes

Marly Barry

Hematology Department, Department Hospital, Boulogne-Sur-Mer

Helene Demarquette

Hematology Department, Department Hospital, Dunkerque

Marie-Noelle Certain

Hematology Department, Department Hospital, Mâcon

Isabelle Plantier

Hematology Department, Department Hospital, Roubaix

Murielle Roussel

Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France

Benjamin Hébraud

Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France

Thomas Filleron

Biostatistics Department, Institut Claudius Regaud, IUCT-O, Toulouse

Michel Attal

Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France

Hervé Avet-Loiseau

Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse